Welcome to another episode of Biotechnology Focus radio!
This episode we will be discussing how new biomarkers found in maternal blood could prevent stillbirth, a new therapy for patients with partial spinal cord injuries, an investment from the Government of Canada, and Inversago closes their first series A financing round.
Listen on to find out more details!
NEW BIOMARKERS FOUND IN MATERNAL BLOOD COULD PREVENT STILLBIRTH
BREATHTAKING THERAPY HAS HIGH POTENTIAL FOR SPINAL CORD PATIENTS
Drs. Gillian Muir (left) and Valerie Verge. (Photo: Debra Marshall)
INVESTING IN HEALTH RESEARCH MITIGATES RISK FOR PATIENTS AND THE CANADIAN HEALTH SYSTEM
INVERSAGO PHARMA CLOSES FIRST SERIES A FINANCING ROUND FOR $7-M
(Photo Credit: Inversago)